#Italy #Vienna #neurosurgery #Esaote #I-Genius

Esaote's Innovative Leap into Neurosurgery with I-Genius

Esaote, the Italian leader in medical imaging technology, has made significant strides into the field of neurosurgery with the introduction of I-Genius, an advanced intraoperative magnetic resonance imaging (MRI) system. This groundbreaking innovation was showcased at the 25th Annual EANS Congress held in Vienna from October 5 to 9, where the latest findings in glioma surgeries were presented, marking a pivotal moment for the medical community.

The Need for Innovative Solutions in Neurosurgery

Gliomas, representing approximately 81% of primary malignant brain tumors, are challenging to operate on due to their invasive nature and the difficulty surgeons face in differentiating tumor tissue from healthy brain tissue. The most prevalent glioma subtype, glioblastoma, has an alarmingly low five-year survival rate of just 5%. The main objective of surgery is to remove as much of the tumor as possible; however, the risks of leaving behind residual disease are high owing to the complexities involved during surgical procedures. Studies indicate that a partial resection often leads to tumor recurrence, necessitating innovative intraoperative imaging solutions.

I-Genius: A Game-Changer in Surgical Procedures

Developed in collaboration with leading neurosurgeons, I-Genius addresses critical needs during brain surgeries. Unlike traditional closed MRI systems—which are costly and complex—I-Genius features an open design that enhances usability and minimizes risks during procedures. With specialized surgical tables and accessories fully compatible with MRI, patients can remain in the same position throughout the surgery, allowing for rapid imaging and immediate confirmation of tumor removal before the cranial closure. This innovative setup significantly reduces surgical time and complications, providing a safer experience for patients.

The Importance of Real-Time Imaging

During the EANS symposium titled “Experience Meets Innovation: How I-Genius MRI Will Transform Neurosurgery,” Dr. Roberto Herrera, Head of Neurosurgery at Adventist Clinic Belgrano in Buenos Aires, emphasized the system's transformative potential. He noted, “The true innovation of I-Genius lies in its ability to provide intraoperative imaging at every stage of neurosurgery. This enables surgeons to excise the lesion, immediately verify results, reassess how to proceed, and continue confidently.” The capability for repeated imaging throughout the procedure adds a level of reassurance previously unattainable in neurosurgery.

Esaote's Commitment to Innovation

According to Franco Fontana, CEO of Esaote, “I-Genius marks a significant milestone for our company. This launch is indicative of our commitment to technological innovation, applied research, and close collaboration with the clinical community.” The introduction of this intraoperative MRI system is not just about enhancing surgical safety; it is also about contributing to patients' quality of life.

Esaote has established itself as a leader in medical imaging (including ultrasound and specialized MRI), employing over 1,300 individuals globally—half of whom are based in Italy. With annual investments of around 13% of consolidated sales in research and development, Esaote continues to forge ahead, expanding its footprint in over 100 countries.

Conclusion

Esaote's I-Genius is set to revolutionize neurosurgery, providing surgeons with indispensable tools to enhance outcomes for patients. As the medical field continues to advance, innovations like I-Genius will pave the way for safer, more efficient surgical practices, ultimately leading to improved survival rates for patients with complex brain tumors. As we witness the evolution of medical technology, it's evident that the future of neurosurgery is bright with the advent of systems like I-Genius.

For more information, visit Esaote's official website.